Barbara Zaggia

1.6k total citations
24 papers, 967 citations indexed

About

Barbara Zaggia is a scholar working on Surgery, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Barbara Zaggia has authored 24 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 16 papers in Cancer Research and 15 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Barbara Zaggia's work include Adrenal and Paraganglionic Tumors (22 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Pituitary Gland Disorders and Treatments (9 papers). Barbara Zaggia is often cited by papers focused on Adrenal and Paraganglionic Tumors (22 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Pituitary Gland Disorders and Treatments (9 papers). Barbara Zaggia collaborates with scholars based in Italy, Germany and France. Barbara Zaggia's co-authors include Massimo Terzolo, Marco Volante, Fulvia Daffara, Silvia De Francia, Alfredo Berruti, F. Porpiglia, Alfredo Berruti, Arianna Ardito, Enrico Bollito and Cristian Fiori and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and The Journal of Urology.

In The Last Decade

Barbara Zaggia

23 papers receiving 946 citations

Peers

Barbara Zaggia

SURGE

EDM

GENET

NEURO

Thomas Kerkhofs Netherlands

Alfredo Berruti Italy

Shamim Ejaz United States

G. Abiven France

Montserrat Ayala‐Ramirez United States

Maria Candida Barisson Villares Fragoso Brazil

Arianna Ardito Italy

Christopher P. Bambach Australia

José Gaal Netherlands

Katherine I. Wolf United States

Thomas Kerkhofs Netherlands

Barbara Zaggia

552 ×0.6

SURGE

406 ×0.6

368 ×0.6

EDM

160 ×0.7

GENET

42 ×0.7

NEURO

Citations per year, relative to Barbara Zaggia Barbara Zaggia (= 1×) peers Thomas Kerkhofs

Countries citing papers authored by Barbara Zaggia

Since Specialization

Citations

This map shows the geographic impact of Barbara Zaggia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Zaggia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Zaggia more than expected).

Fields of papers citing papers by Barbara Zaggia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Zaggia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Zaggia. The network helps show where Barbara Zaggia may publish in the future.

Co-authorship network of co-authors of Barbara Zaggia

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Zaggia. A scholar is included among the top collaborators of Barbara Zaggia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Zaggia. Barbara Zaggia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roca, Elisa, Alfredo Berruti, Silviu Sbiera, et al.. (2017). Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer. Endocrine Related Cancer. 24(7). 319–327. 28 indexed citations

Berruti, Alfredo, Salvatore Grisanti, Mélanie Claps, et al.. (2017). Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 102(4). 1358–1365. 100 indexed citations

Duregon, Eleonora, Rocco Cappellesso, Valeria Maffeis, et al.. (2016). Validation of the prognostic role of the "Helsinki Score” in 225 cases of adrenocortical carcinoma. Human Pathology. 62. 1–7. 66 indexed citations

Porpiglia, F., Cristian Fiori, Fulvia Daffara, et al.. (2015). Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome?. Journal of Endocrinological Investigation. 39(4). 465–471. 11 indexed citations

Ardito, Arianna, Ettore Pelosi, Barbara Zaggia, et al.. (2015). 18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma. European Journal of Endocrinology. 173(6). 749–756. 11 indexed citations

Duregon, Eleonora, Marco Volante, Enrico Bollito, et al.. (2015). Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases. Human Pathology. 46(12). 1799–1807. 36 indexed citations

Terzolo, Massimo, Barbara Zaggia, Barbara Allasino, & Silvia De Francia. (2014). Practical treatment using mitotane for adrenocortical carcinoma. Current Opinion in Endocrinology Diabetes and Obesity. 21(3). 159–165. 28 indexed citations

Terzolo, Massimo, Fulvia Daffara, Arianna Ardito, et al.. (2014). Management of adrenal cancer: a 2013 update. Journal of Endocrinological Investigation. 37(3). 207–217. 72 indexed citations

Libé, Rossella, Isabelle Borget, Cristina L. Ronchi, et al.. (2014). Prognostic factors of overall survival of stage III or IV adrenocortical carcinomas (ACC): A multicenter ENS@T study.. Journal of Clinical Oncology. 32(15_suppl). 4106–4106. 1 indexed citations

10.

Terzolo, Massimo, Arianna Ardito, Matthias Kroiß, et al.. (2013). Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. European Journal of Endocrinology. 169(3). 263–270. 101 indexed citations

11.

D’Avolio, Antonio, Silvia De Francia, Vittoria Basile, et al.. (2013). Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. Pharmacogenetics and Genomics. 23(6). 293–300. 35 indexed citations

12.

Terzolo, Massimo, Arianna Ardito, Barbara Zaggia, et al.. (2012). Management of adjuvant mitotane therapy following resection of adrenal cancer. Endocrine. 42(3). 521–525. 29 indexed citations

13.

Ardito, Arianna, et al.. (2012). Mitotane treatment for adrenocortical carcinoma: an overview.. PubMed. 37(1). 9–23. 19 indexed citations

14.

Fiori, Cristian, Fulvia Daffara, Barbara Zaggia, et al.. (2012). 1105 Does nephrectomy during adrenalectomy for adrenal cancer improve oncological results?. European Urology Supplements. 11(1). e1105–e1105a. 2 indexed citations

15.

Porpiglia, F., Cristian Fiori, Fulvia Daffara, et al.. (2010). Retrospective Evaluation of the Outcome of Open Versus Laparoscopic Adrenalectomy for Stage I and II Adrenocortical Cancer. European Urology. 57(5). 873–878. 134 indexed citations

16.

Sperone, Paola, Annamaria Ferrero, Fulvia Daffara, et al.. (2010). Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study. Endocrine Related Cancer. 17(2). 445–453. 110 indexed citations

17.

Porpiglia, F., Cristian Fiori, Fulvia Daffara, et al.. (2010). 25 DOES NEPHRECTOMY DURING RADICAL ADRENALECTOMY FOR ADRENOCORTICAL CANCER AFFECT ONCOLOGICAL RESULTS?. The Journal of Urology. 183(4S). 4 indexed citations

18.

Porpiglia, F., Cristian Fiori, Roberto Mario Scarpa, et al.. (2009). 740 THE ROLE OF SURGERY IN THE MANAGEMENT OF RECURRENT ADRENOCORTICAL CARCINOMA: RESULTS OF A RETROSPECTIVE STUDY. European Urology Supplements. 8(4). 305–305. 5 indexed citations

19.

Reimondo, Giuseppe, Silvia Bovio, Barbara Allasino, et al.. (2008). The combined low-dose dexamethasone suppression corticotropin-releasing hormone test as a tool to rule out Cushing's syndrome. European Journal of Endocrinology. 159(5). 569–576. 15 indexed citations

20.

Daffara, Fulvia, Silvia De Francia, Giuseppe Reimondo, et al.. (2008). Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly. Endocrine Related Cancer. 15(4). 1043–1053. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact